Unknown

Dataset Information

0

Merlin deficiency alters the redox management program in breast cancer.


ABSTRACT: The expression of Merlin tumor suppressor protein encoded by Neurofibromin 2 (NF2) gene is remarkably decreased in metastatic breast cancer tissues. In order to recapitulate clinical evidence, we generated a unique, conditional Nf2-knockout (Nf2-/- ) mouse mammary tumor model. Merlin-deficient breast tumor cells and Nf2-/- mouse embryonic fibroblasts (MEFs) displayed a robustly invasive phenotype. Moreover, Nf2-/- MEFs presented with notable alterations in redox management networks, implicating a role for Merlin in redox homeostasis. This programmatic alteration resonated with pathways that emerged from breast tumor cells engineered for Merlin deficiency. Further investigations revealed that NF2-silenced cells supported reduced activity of the Nuclear factor, erythroid 2 like 2 antioxidant transcription factor, concomitant with elevated expression of NADPH oxidase enzymes. Importantly, mammary-specific Nf2-/- in an Mouse mammary tumor virus Neu + murine breast cancer model demonstrated accelerated mammary carcinogenesis in vivo. Tumor-derived primary organoids and cell lines were characteristically invasive with evidence of a dysregulated cellular redox management system. As such, Merlin deficiency programmatically influences redox imbalance that orchestrates malignant attributes of mammary/breast cancer.

SUBMITTER: Mota M 

PROVIDER: S-EPMC8024723 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Merlin deficiency alters the redox management program in breast cancer.

Mota Mateus M   Metge Brandon J BJ   Hinshaw Dominique C DC   Alsheikh Heba A HA   Chen Dongquan D   Samant Rajeev S RS   Shevde Lalita A LA  

Molecular oncology 20210201 4


The expression of Merlin tumor suppressor protein encoded by Neurofibromin 2 (NF2) gene is remarkably decreased in metastatic breast cancer tissues. In order to recapitulate clinical evidence, we generated a unique, conditional Nf2-knockout (Nf2<sup>-/-</sup> ) mouse mammary tumor model. Merlin-deficient breast tumor cells and Nf2<sup>-/-</sup> mouse embryonic fibroblasts (MEFs) displayed a robustly invasive phenotype. Moreover, Nf2<sup>-/-</sup> MEFs presented with notable alterations in redox  ...[more]

Similar Datasets

| S-EPMC6148973 | biostudies-literature
| S-EPMC4735628 | biostudies-literature
| S-EPMC5430628 | biostudies-literature
| S-EPMC4165339 | biostudies-literature
| S-EPMC3220570 | biostudies-literature
2022-09-14 | GSE173997 | GEO
| S-EPMC3412017 | biostudies-literature
| S-EPMC5591043 | biostudies-literature
| S-EPMC6128040 | biostudies-literature
| S-EPMC3789164 | biostudies-literature